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ABSTRACT Changes in synaptic strength are impor-
tant for synaptic development and synaptic plasticity.
Most directly responsible for these synaptic changes are
alterations in synaptic receptor number and density.
Although alterations in receptor density mediated by
the insertion, lateral mobility, removal, and recycling of
receptors have been extensively studied, the dynamics
and regulators of intracellular scaffolding proteins
have only recently begun to be illuminated. In particu-
lar, a closer look at the receptor-associated proteins,
which bind to receptors and are necessary for their
synaptic localization and clustering, has revealed
broader functions than previously thought and some
rather unexpected thematic similarities. More than just
“placeholders” or members of a passive protein “scaf-
fold,” receptor-associated proteins in every synapse
studied have been shown to provide a number of
signaling roles. In addition, the most recent state-of-the-
art imaging has revealed that receptor-associated pro-
teins are highly dynamic and are involved in regulating
synaptic receptor density. Together, these results chal-
lenge the view that receptor-associated proteins are
members of a static and stable scaffold and argue that
their dynamic mobility may be essential for regulating
activity-dependent changes in synaptic strength.—Bru-
neau, E. G., Esteban, J. A., Akaaboune, M. Receptor-
associated proteins and synaptic plasticity. FASEB J. 23,
679–688 (2009)
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The recruitment and maintenance of a high density
of ionotropic receptors at postsynaptic sites is necessary
for proper synaptic function. Associated with receptors
is a group of proteins that make up the postsynaptic
density and provide an intracellular scaffold for recep-
tor anchoring. Although traditionally thought to serve
primarily as receptor anchors or placeholders, recep-
tor-associated proteins have been shown recently to
play a central role in the regulation of intracellular
signaling and the maintenance of the scaffolding com-
plex. Through their many protein-interacting domains,
receptor-associated proteins are able to regulate di-
rectly and/or indirectly the dynamics of postsynaptic
receptors and other scaffold proteins, implicating them
as central organizers of the postsynaptic apparatus.
Mounting evidence has also challenged the view of
the receptor-associated protein as a member of a rela-
tively stable postsynaptic scaffold. Interestingly, the
picture emerging from recent work is a postsynaptic
structure in which receptor-associated proteins are
highly dynamic, selectively regulated, and crucially in-
volved in modulating changes in receptor density, both
during development and at the mature, dynamic
postsynaptic apparatus.
At the cholinergic neuromuscular junction (NMJ),
the receptor-associated protein of the synapse (rapsyn)
is responsible for receptor anchoring and is crucial for
the initiation of acetylcholine receptor (AChR) cluster-
ing (1, 2). Analogously, at inhibitory synapses in the
central nervous system, the receptor-associated protein
gephyrin is necessary for the aggregation of glycine (3,
4) and many subtypes of -aminobutyric acid (GABAA)
receptors (5, 6). In excitatory central synapses, the
glutamatergic AMPA and NMDA receptors are similarly
tethered in place by protein linkers. Anchoring at
glutamatergic synapses, however, is not mediated by a
single receptor-associated protein, but instead by a
family of PDZ-domain-containing proteins, including
the most prevalent member, PSD-95, which binds di-
rectly to NMDA receptors and indirectly to AMPA
receptors (7).
Rapsyn, gephyrin, and PSD-95 are not the only
receptor-associated proteins that have been identified
at cholinergic, GABAergic, glycinergic, and glutamater-
gic synapses. A handful of other important proteins
have been shown to directly bind to and potentially
regulate receptor trafficking, activity, or surface expres-
sion. However, rapsyn, gehpyrin, and PSD-95 have been
most fully described in terms of structure, binding
partners, and dynamics, and they have all been shown
to be critically involved in receptor clustering at
postsynaptic sites. Although the roles that a number of
other scaffolding proteins play in the trafficking and
clustering of receptors will be discussed, we will focus
this review on rapsyn, gephyrin, and PSD-95: compo-
nents of the intracellular scaffold that illustrate a num-
ber of the ways in which the character of the receptor-
associated protein is being re-envisioned.
RAPSYN AND CHOLINERGIC SYNAPSES
At the peripheral NMJ, pentameric AChRs mediate the
activation of muscle action potentials. As with all syn-
aptic sites, the clustering of receptors in direct apposi-
tion to the presynaptic nerve terminal is important for
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strong and effective synaptic transmission. Proteins that
regulate the accumulation of AChRs at the synapse are
therefore essential for establishing synaptic transmis-
sion and regulating synaptic strength. One protein
shown to bind to the AChR through yeast two-hybrid
studies is the wnt signaling component, adenomatous
polyposis coli (APC) (8). Interference of this binding
with dominant negative constructs decreased the num-
ber of AChR clusters on cultured muscle cells, indicat-
ing that wnt signaling may have some regulatory effect
on AChR clustering. The other identified binding
partner of the AChR is rapsyn. Rapsyn binds both to
-catenin (9) and to –dystroglycan (2, 10, 11), which
both have the potential to anchor receptors to the
intracellular protein scaffold (Fig. 1A).
The essential role of rapsyn in the anchoring of
AChRs to the scaffold and the clustering of receptors at
postsynaptic sites in vivo is illustrated by the complete
lack of clustered receptors at nerve endplates in
rapsyn/ mice and the lack of receptor clusters on
myotubes generated from these mice, even as overall
surface AChR expression does not decrease (12, 13).
Interestingly, it has recently been shown that depletion
of rapsyn expression with RNAi in adult rat muscle
fibers in vivo also results in the rapid disappearance of
AChR clusters, showing that rapsyn is necessary for
both the formation and the maintenance of AChR
clustering (14). In contrast to muscle cells, the size and
density of nicotinic AChR clusters in neurons of the
superior cervical ganglia are not altered in rapsyn/
mice, indicating that rapsyn may play a different role in
muscle cells and neurons (4).
Rapsyn and AChR are expressed on the muscle
surface in a 1:1 ratio (15). Changes in this ratio have
been shown to alter surface AChR density, suggesting
that modulation of rapsyn expression could regulate
receptor density (16–18). One scaffolding component
that has been shown to alter rapsyn protein expression
is -catenin. Aside from potentially linking the rapsyn-
AChR complex to cytoskeletal components through
-catenin, -catenin has been shown recently to regu-
late rapsyn protein levels by altering mRNA expression
(19). In this study, the introduction of a metabolically
stabilized -catenin construct decreased both the pro-
duction of a rapsyn reporter and the number of AChR
clusters on muscle cells. Electroporation of this con-
struct in vivo also caused a decrease in the size of NMJs.
Conversely, decreases in -catenin have been shown to
increase AChR expression both in vitro and in vivo (9,
20). The generation of -catenin conditional-knockout
mice has provided evidence that muscle -catenin is
not only involved in the postsynaptic maturation but
also in presynaptic differentiation by controlling retro-
grade signals that are required for presynaptic differ-
entiation through a canonical signaling pathway. Fur-
ther work will be needed to determine the identity of
these retrograde signals generated by -catenin action.
Another recent study has shown that receptor cluster-
ing at postsynaptic sites is mediated by the increased
association of rapsyn to calpain, a protease that initiates
AChR dispersal when unbound (21). When calpain
activity was blocked, either by pharmacological agents
or RNAi, receptor stability was compromised. Since
rapsyn is expressed almost exclusively at the synapse in
the mature muscle cell, rapsyn’s association to calpain
prevents declustering only at synaptic sites and allows
extrasynaptic dispersal. It is possible that rapsyn/cal-
Figure 1. Rapsyn, gephyrin, and PSD-95 as scaffolding pro-
teins and signaling molecules. An illustration of rapsyn,
gephyrin, and PSD-95 (red) and some of the scaffolding
proteins (blue) and signaling molecules (yellow) with which
they associate. A) At acetylcholine receptor clusters, rapsyn
binds the intracellular portion of the receptor subunits. The
activation of rapsyn and the clustering of receptors are
initiated by agrin or laminin, and rapsyn stabilizes receptors
through a direct association with -dystroglycan and -cate-
nin. Cytoskeletal reorganization is controlled by the associa-
tion of rapsyn to calpain. B) At inhibitory synapses, glycine
and/or GABA receptors mediate neurotransmission. The
activation of gephyrin clustering requires glycine receptor
activity, and gephyrin binds directly to the intracellular loop
of the glycine receptor -subunit. Direct binding of gephyrin
to the GABA receptor has not been observed, but gephyrin is
required for 2-GABA receptor subunit clustering. Like
rapsyn, gephyrin links receptors to the intracellular cytoskel-
eton (through mena/VASP) and regulates signaling through
interactions with collybistin. C) The clustering of AMPA,
NMDA, and nACh receptors at excitatory central synapses is
mediated by PDZ proteins, including the most prevalent
member of that family, PSD-95. PSD-95 binds directly to the
NMDA receptor and indirectly to AMPA receptors through
intermediate TARP and/or SAP-97 proteins. Although
PSD-95 associates with nAChRs in central synapses, it is not
known whether this interaction is direct.
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pain association/dissociation may be one of mecha-
nisms that underlies the dramatic difference in recep-
tor density at synaptic and extrasynaptic sites.
In addition to its critical role in AChR clustering,
rapsyn also may play a similar role in clustering other
scaffolding proteins. Studies investigating the agrin-
signaling cascade, which initiates receptor clustering at
nerve endplates in vivo, support this conclusion, impli-
cating rapsyn not only as an integral component of this
clustering cascade, but a central component that ac-
tively recruits other scaffolding components (22). This
conclusion is supported by evidence that postsynaptic
sites on muscles from rapsyn/ mice show disruptions
of the dystrophin-glycoprotein complex, with near-
complete absence of utrophin and syntrophin (13). It is
not clear whether the lack of intracellular scaffolding
proteins in rapsyn/ mice is directly linked to the
absence of rapsyn itself, or whether the resulting lack of
AChR clustering prevents the accumulation of scaffold-
ing proteins. Evidence for the latter possibility is sup-
ported by recent findings from our laboratory. In this
work, we demonstrated that exposure of AChRs labeled
with Alexa 594 conjugates on cultured myotubes to
low-powered laser light caused the dissipation of the
illuminated AChRs from clusters, which, in turn, in-
duced the removal of scaffolding proteins and pre-
vented the accumulation of new AChRs and associated
scaffolding proteins at the illuminated site. Genetic
approaches from other labs have similarly found that
AChRs are required for the proper subsynaptic local-
ization of rapsyn in zebrafish (23, 24). Regardless of the
particular mechanism, the lack of scaffolding proteins
at postsynaptic sites in rapsyn/ mice indicates that
rapsyn is involved, at least indirectly, in the clustering of
the intracellular scaffolding complex. These emerging
data implicate rapsyn not only as an AChR anchor, but
also as a regulator of signaling cascades, which them-
selves are capable of altering AChR clustering.
The regulation of receptor density at synaptic sites
has been extensively studied at the NMJ, and the
insertion, removal, recycling, and lateral migration of
receptors into and out of the postsynaptic membrane
have all been shown to be involved in maintaining a
dynamic equilibrium of synaptic AChRs (25–28). How-
ever, little is known about the dwell-time of the rapsyn
molecule at the postsynaptic scaffold. Recently, our lab
has begun to examine the dynamics of rapsyn, yielding
interesting observations about the synaptic stability and
regulation of this protein. Using fluorescent recovery
after photobleaching (FRAP), we have found that
rapsyn turns over at aneural cluster sites on cultured
muscle cells more rapidly than AChRs and that rapsyn
is unaffected by protein phosphatase inhibition that
causes significant changes in receptor removal and
insertion (29). This result supports previous biochem-
ical analysis indicating that the metabolic turnover of
rapsyn in muscle cells is very rapid (30). Recent in vivo
studies in our lab have confirmed that rapsyn turns over
rapidly at the innervated NMJ (unpublished data).
While AChR turnover and trafficking are dramati-
cally altered by activity (25, 28, 31), rapsyn turnover
in vivo appears to be unaffected by postsynaptic activity
blockade (unpublished data), indicating that both
in vitro and in vivo rapsyn and AChRs are regulated by
different mechanisms. It is possible that changing the
turnover of receptor-associated proteins at cluster sites
may be a factor regulating receptor density, and this
intriguing possibility is currently under investigation in
our lab. At the very least, the fast turnover of rapsyn
could allow for rapid changes in rapsyn density within
synaptic domains, which could drive alterations in the
intracellular scaffold morphology and local AChR den-
sity during development and aging.
In humans, rapsyn has been implicated in muscular
dystrophies, including myasthenic syndrome. One hall-
mark of this illness is a dramatic decrease in postsynap-
tic AChR density, and mutations in the rapsyn gene or
promoter region have been shown to be the primary
cause of synaptic pathogenesis in a number of reported
cases (32–35). In addition to the disruption of junc-
tional folding caused by rapsyn mutations or deficien-
cies, mutations in the rapsyn protein cause a decrease
in the number of postsynaptic rapsyn and receptor
proteins. The use of mutant rapsyn-GFP fusion proteins
should enable a very complete investigation of the
molecular-level pathophysiology of these muscular dys-
trophies.
GEPHYRIN AND GLYCINERGIC SYNAPSES
In inhibitory synapses of the brain and spinal cord, the
majority of synaptic transmission is enabled by glycine
and GABA receptors. GABAA receptors are pentameric
ionotropic receptors composed of a wide diversity of
receptor subunits. The intracellular loops of these
receptor subtypes have been shown to associate with a
number of proteins, including the Golgi-specific DHHC
zinc finger protein (GODZ), phospholipase C-related,
catalytically inactive proteins (PRIP), Plic-1, and the
GABA receptor-associated protein (GABARAP), all of
which will be described below. However, one protein
that has been shown to be crucial for the clustering of
glycine receptors and many types of GABAA receptors is
the 93-kDa protein gephyrin.
Analogous to rapsyn, gephyrin has been shown to
play a crucial role in the clustering and localization of
glycine and GABAA receptors at inhibitory synapses in
the brain and spinal cord (3–6, 36, 37). Gephyrin is a
tubulin-binding protein that associates directly with the
intracellular loop of the glycine receptor -subunit and
indirectly through a putative linker protein to the
intracellular portion of -subunit containing GABAA
receptors (Fig. 1B) (38). Similar to rapsyn knockouts,
glycine receptor clustering is absent in mice that are
lacking gephyrin either because of genetic deletion or
RNAi (3, 4, 39); at the same time, 2- and 2-containing
GABAA receptor clustering is dramatically decreased in
gephyrin knockout mice (6, 40, 41), even though
overall GABAAR surface expression remains unaffected
(6, 42). Further, it has been shown that GABAergic
inhibitory postsynaptic currents, synaptic plasticity and
performance on learning tasks are all significantly
compromised when gephyrin expression or clustering
is disrupted (41, 43), while whole cell GABA-mediated
currents are unchanged (41). This indicates that gephy-
rin may be necessary for both the initiation and main-
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tenance of inhibitory receptor clustering, which is
required for proper synaptic function.
In addition to functional binding domains on gephy-
rin, which allow self-association and the association of
gephyrin with scaffolding proteins, gephyrin binds to a
number of signaling molecules that may help regulate
synaptic structure, including collybistin a guanine nu-
cleotide exchange factor. Similar to the role of calpain
in AChR clustering at the NMJ, collybistin has been
proposed to modulate cytoskeletal remodeling and be
involved in gephyrin and GABAAR clustering (43–45).
For example, collybistin knockout mice display dra-
matic decreases in GABAAR clustering in amygdala and
hippocampus and show deficits in synaptic plasticity
and learning (43). Also, on the list of regulatory
proteins that bind to and are potentially modulated by
gephyrin is RAFT1 (mTOR), which is a regulator of
mRNA translation that has been shown to be active only
if bound to gephyrin (46). Finally, gephyrin binds to
the actin-associating mena/VASP (vasodilator stimu-
lated protein) and profilin proteins (47), which are
involved in actin regulation, implying that gephyrin not
only relies on the cytoskeleton for anchoring but may
be directly involved in regulating cytoskeletal dynamics
and thereby altering synaptic structure.
Although its association with GABAARs is likely tran-
sient and restricted to export from the Golgi, GODZ
has been shown to bind directly to the palmitoylated
fragments of the GABAAR intracellular loop (48).
GODZ is localized to Golgi regions, so it has been
suggested that it palmitoylates GABAARs before exocy-
tosis. A protein that links to GABAARs both intracellu-
larly and at synaptic sites is Plic-1 (49). Overexpression
of the ubiquitin-like Plic-1 protein has been shown to
increase the intracellular half-life of the GABAAR,
potentially by disrupting polyubiquitination, and in-
crease surface expression of GABAARs. Introduction of
a GABAAR-Plic-1 interfering peptide decreases surface
expression of GABAARs. This suggests that Plic-1 may
be involved in mediating GABAAR interactions with the
intracellular scaffold.
By far, the most studied of the GABAAR associated
proteins is the ubiquitin-like, 117-aa GABARAP.
GABARAP binds to the large intracellular loop of the
gamma GABAA subunits and colocalizes with GABAA,
mostly in intracellular compartments. Initial findings
that GABARAP increases GABAA clustering when coex-
pressed in heterologous cells suggested that GABARAP
may serve to link GABAA receptors to an intracellular
scaffold, much like the role of rapsyn in AChR cluster-
ing. However, GABARAP knockout mice were shown to
cluster GABARs normally and were phenotypically in-
distinguishable from wild-type mice (50). The intracel-
lular colocalization of GABARAP with GABAARs in
neurons suggests that GABARAP may be more involved
with the regulation of GABAAR trafficking or targeting,
a supposition that has been supported by recent work
(51, 52).
GABARAP binds with a number of other proteins
that serve to potentially modify and regulate the
GABAAR. For example, GABARAP binds to the PDZ
protein GRIP-1 (53) and to NSF (51, 54), which are
both involved in the regulation of AMPAR trafficking in
excitatory synapses (55). GABARAP has also been
shown to associate, mostly in intracellular compart-
ments, with PRIP, a protein that also binds to protein
phosphatase 1- (PP1-) (56). Mice deficient in PRIP
show significant increases in PP1- activity, suggesting
that PRIP modifies the GABAAR by indirectly bringing
it into close association with PP1-. While PRIP knock-
out mice show no change in GABAA surface receptor
number, binding sites, or electrophysiology, they do
show alterations in response to GABAAR drugs and
cofactors, and the mice have behavioral impairments in
coordination (56). It has therefore been suggested that
PRIP and PP1- are involved in phospho-dependent
modulation of GABAA that is enabled by their associa-
tion with GABARAP.
A more direct role of GABARAP in GABAAR-medi-
ated synaptic plasticity was recently demonstrated in
cerebellar Perkinje neurons (57). In cell culture prep-
arations, it was shown that the association of GABARAP
with both GABAARs and microtubules was required for
the late phase of rebound potential (RP). In this study,
they found that competitive inhibition of GABARAP-
GABAAR association prevented late-phase RP without
altering subcellular localization or surface expression
patterns of GABAARs. A GABARAP truncation mutant
unable to bind to tubulin similarly prevented RP while
leaving surface expression and localization unaltered.
Together, these studies suggest that GABARAP is a
signaling platform that may aid in the trafficking,
delivery, and modification of GABAARs but is likely not
involved in the anchoring of GABAARs to the intracel-
lular scaffold or the accumulation of receptors at
synaptic sites.
The dynamics of the glycine receptor have recently
been investigated in a series of elegant single-particle
tracking experiments. Twenty-five years ago, investiga-
tion of AChR lateral diffusion led to the “diffusion-trap”
model of synaptic receptor accumulation (58). Single-
particle imaging studies have allowed a more direct
investigation of receptor mobility at glycinergic syn-
apses. Using coated beads, rapidly bleaching protein
fluorophores and nonbleaching quantum dots, we have
shown that individual glycine receptors move with
near-Brownian motion outside of synaptic sites but slow
considerably once they are within the synaptic region
(59–61). Recently, in a series of elegant experiments,
the Triller group has shown that glycine receptors, but
not GABAARs, are highly dynamic in response to
NMDAR activity and intracellular calcium release (36).
Gephyrin appears to be critical for the trapping and
stabilization of glycine receptors, as cotransfection of
glycine receptors and gephyrin in heterologous cells or
the overexpression of gephyrin in neuronal cells dra-
matically decreases receptor lateral mobility (59). Sim-
ilarly, when gephyrin surface expression is decreased
with shRNA or with a dominant-negative gephyrin
construct, glycine receptor mobility increases (61).
Although the dynamics of GABAA receptors have not
been examined as extensively as ACh or glycine recep-
tors, studies using recombinant GABAARs containing
either the bungarotoxin binding site (62) or a tag
allowing electrophysiological identification (63) have
found that GABAARs are rapidly inserted and removed
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at the neuronal membrane and that they shuttle rapidly
between synaptic and extrasynaptic regions by lateral
diffusion. As with glycine receptors, gephyrin appears
to play a critical role in the regulation of GABAAR
dynamics, as disruption of gephyrin with RNAi de-
creases the number and density of GABAAR clusters,
while increasing GABAAR cluster mobility on the sur-
face of cultured hippocampal neurons (40).
The dynamics of gephyrin itself have also recently
begun to be investigated. Using recombinant gephyrin
fused to a fluorescent marker and time-lapse imaging,
Hanus et al. (64) measured the overall movement of
individual gephyrin clusters in cultured spinal cord
neurons following pharmacological manipulation. By
examining intracluster fluctuations over short time
periods and the movement of the entire cluster over
longer time periods, we found that gephyrin dynamics
within clusters were decreased when F-actin was dis-
rupted, while movements of the entire clusters were
tubulin dependent. Interestingly, synaptic activity spe-
cifically stabilized the intracluster movement of gephy-
rin. Although these studies did not examine the inser-
tion, removal, or lateral mobility of gephyrin into or out
of individual synaptic sites, they nevertheless support a
model in which receptor-associated protein dynamics
potentially play a role in regulating changes in receptor
density at postsynaptic sites.
PSD-95 AND GLUTAMATERGIC SYNAPSES
Most excitatory transmission in the mammalian brain is
mediated by glutamate. At glutamatergic synapses, an-
choring of the main receptor types is facilitated by a
family of PDZ binding proteins. Most ubiquitous and
best characterized of these glutamatergic postsynaptic
density (PSD) proteins is PSD-95, which binds directly
to NMDARs through the C terminus of the NR2
subunit, and indirectly to AMPARs through interac-
tions with SAP-97 and auxiliary TARPs (Fig. 1C) (65–
69). Unlike rapsyn or gephyrin, PSD-95 does not ap-
pear to be necessary for initial NMDA receptor
clustering: although PSD-95 clusters NMDARs when
the two proteins are coexpressed in heterologous cells
(70), genetic knockouts still display NMDAR clusters,
and loss-of-function constructs have no effect on
postsynaptic NMDAR accumulation or NMDAR-medi-
ated excitatory postsynaptic currents (EPSCs) (71, 72).
Further, time-lapse imaging indicates that NMDA re-
ceptors actually begin to cluster at postsynaptic sites
prior to the arrival of PSD-95 (73). However, PSD-95
does appear to contribute to some extent to NMDAR
clustering in mature synapses. For example, simulta-
neous shRNA-mediated knockdown of PSD-95 and the
closely related protein PSD-93 (chapsyn-110) produces
a small decrease in NMDAR-mediated synaptic trans-
mission, whereas each individual knockdown does not
(74). Nevertheless, and in contrast to its limited role on
NMDAR targeting, there is abundant evidence that
PSD-95 is most critically involved in regulating AMPA
receptor density at synapses. For example, acute reduc-
tion in PSD-95 levels results in decreased AMPA recep-
tor-mediated synaptic responses (71, 72). Conversely,
overexpression of PSD-95 greatly increases AMPA re-
ceptor presence at synapses, with no effect on NMDA
receptors (68, 71, 72, 75–78). On the basis of these
combined observations, PSD-95 is thought to be a
fundamental molecular scaffold for the anchoring of
AMPA receptors at the postsynaptic membrane. In
agreement with this interpretation, it has been recently
shown that PSD-95 retains (or stabilizes) AMPA recep-
tors at synapses by restricting their lateral diffusion
within the postsynaptic membrane (79). This mecha-
nism can effectively modulate synaptic strength in a
subsecond timescale (80).
Similar to rapsyn and gephyrin, PSD-95 has multiple
interaction domains capable of mediating self-associa-
tion and binding structural proteins (81–83). PSD-95
also serves as a central organizer of a number of
signaling molecules (82, 83–87). For example, PSD-95
associates with Src-family kinases, reduces Src-kinase
activity and inhibits the phosphorylation of NMDARs
(87, 88). Also, associated with PSD-95 are Kalirin-7, a
GEF that promotes spine formation, and SPAR, a
Rap-specific GTPase-activating protein (RapGAP),
which similarly stimulates spine growth (86, 89). This
function of PSD-95 as a signaling scaffold is likely to be
responsible for its role in the modulation of synaptic
plasticity (90, 91).
A final receptor that has been shown to associate with
PSD-95 in central synapses is the heteromeric nicotinic
AChR (92). Although rapsyn has been shown to be
inessential for the clustering on nonmuscle isoforms of
the AChR expressed in the CNS and ciliary ganglion
(4), PSD-95 has been shown to bind to 3- and 5-
containing AChRs in vitro. PDZ association has been
shown to be essential for the maturation of nonmuscle
nicotinic synapses, and PSD-95 also assists in ACh
receptor-mediated signal transduction (92). In central
synapses, AChRs are thought to play a regulatory role in
neurotransmission, and their activity can be modulated
by nicotine (93). It is not entirely clear how nicotine
regulates these receptors, but studies in postmortem
human brain tissue and in mice chronically exposed to
nicotine have shown an increase in the number of
nAChRs in central synapses (94, 95). Decreased AChR
expression in the CNS has been linked to a number of
disorders, including attention deficit disorder, Alzhei-
mer’s disease, Parkinson’s disease, and schizophrenia
(96–98). Because most nAChRs in the CNS are local-
ized presynaptically rather than postsynaptically (99),
more work will have to be done to illuminate the
significance of PSD-95-nAChR association in these dis-
eases.
As with rapsyn and gephyrin, recent work has focused
on the turnover of PSD-95 as a means of controlling the
synaptic localization and density of receptors. Using a
PSD-95 fusion construct in hippocampal cultures
in vitro and FRAP experiments similar to the ones used
to examine rapsyn turnover, investigators have shown
that PSD-95 is a fairly stable component of excitatory
synapses under basal conditions (100, 101). However,
in vivo two-photon excitation of photoactivating GFP
(paGFP) fused to PSD-95 indicated that PSD-95 resi-
dence time at synaptic sites varies with postnatal age
and is regulated by sensory experience (102). This
observation suggests that synaptic activity may con-
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trol the removal and/or insertion of PSD-95 at
synaptic sites, which would, in turn, dramatically alter
AMPA receptor levels and reset receptor density.
Indeed, as mentioned above, experimental manipu-
lation of PSD-95 levels have been shown to dramatically
alter AMPAR-mediated currents by altering synaptic
expression of AMPA receptors (68, 71, 72, 75–78).
Although the role of PSD-95 in synaptic plasticity is
still debated, a number of studies have shown that the
down-regulation of AMPARs resulting from an activa-
tion of NMDARs is mediated by changes in synaptic
expression of PSD-95. For example, NMDAR activation
has been shown to trigger PSD-95 ubiquitination and
proteasomal degradation, which, in turn, leads to
AMPAR down-regulation and synaptic depression
(103). The PSD-95 presence at synapses is also regu-
lated by activity-dependent phosphorylation at Ser-295.
In this case, activation of NMDARs during long-term
depression has been shown to cause PSD-95 dephos-
phorylation and dissociation from synapses (104). Fi-
nally, PSD-95 is targeted and anchored to synaptic
membranes through N-terminal palmitoylation (105,
106). Interestingly, PSD-95 palmitoylation, and there-
fore synaptic association, has been shown to be revers-
ible and regulated by glutamate receptor activation
(107). In conclusion, these three layers of regulation
(ubiquitination, phosphorylation, and palmitoylation)
strongly suggest that PSD-95 presence at synapses can
be dynamically adjusted in response to neuronal activ-
ity, and therefore, constitute a mechanism to modify
AMPA receptor synaptic number during plasticity.
PSD-95 belongs to a family of membrane-associated
guanylate kinases, or MAGUKs (108). There is grow-
ing evidence that several MAGUKs, and not only
PSD-95, are important players in the regulation of
synaptic function and AMPA receptor trafficking
(109). However, their high structural similarity has
made it difficult to ascertain the specific roles of
these synaptic scaffolding proteins, which are likely
to display partially redundant functions in most
experimental settings.
Only recently, acute knockdown (shRNA) and
gene-replacement strategies have started to unveil a
more complex, but hopefully more accurate, picture
of the specific roles of these proteins in synaptic
function and plasticity (74, 91). According to this
new evidence, PSD-93 and PSD-95 together are re-
sponsible for most AMPA receptor presence at syn-
apses in mature neurons. Thus, acute removal of
either MAGUK leads to the loss of roughly 50% of
synaptic AMPA receptors, with the double knock-
down producing an almost complete depletion of
AMPA receptors from synapses (74). The almost
additive effect of the PSD-93 and PSD-95 knockdowns
strongly suggests that these two MAGUKs control
largely separate sets of synapses. Interestingly, this
MAGUK specialization is also reflected at the level of
postnatal development. Thus, immature (2 wk old)
rodent synapses mostly rely on a different synaptic
MAGUK, SAP-102 (74), which is more prevalently
expressed in early postnatal development (110). Fur-
ther work will be necessary to determine whether
differences in MAGUK identity endow individual
synapses with distinct functional properties.
The repertoire of AMPA receptor binding proteins
responsible for receptor trafficking is not limited to
these synaptic scaffolding molecules. In fact, the early
steps of AMPA receptor transport along the biosyn-
thetic pathway are likely to be controlled by a different
set of PDZ proteins. For example, SAP-97, a different
MAGUK that binds the GluR1 subunit of AMPA recep-
tors (111), has been shown to interact with the receptor
at the level of the endoplasmic reticulum and/or
cis-Golgi (112). On a similar note, a macromolecular
complex containing the multi-PDZ protein GRIP1 cou-
ples GluR2-containing AMPA receptor with kinesin
motor proteins for receptor transport along the micro-
tubular cytoskeleton in dendrites (113, 114). In addi-
tion to their role in early trafficking, these PDZ proteins
may also participate in local changes in synaptic AMPA
receptors during plasticity. Thus, SAP-97 has been
implicated in activity-dependent targeting of AMPA
receptors at synapses (71, 72). Conversely, GRIP1 acts
in concert with another PDZ protein, PICK1, to control
the regulated removal and recycling of receptors dur-
ing long-term depression (115–117). More extensive
information on the variety of AMPA receptor binding
proteins and their role in receptor trafficking has been
recently presented in several excellent reviews (7, 109,
119, 120).
FUTURE DIRECTIONS AND UNANSWERED
QUESTIONS
Extensive study of AChRs at the peripheral NMJ and
AMPARs, GABAARs, and glycine receptors at central
synapses has detailed much about receptor dynamics.
At the NMJ, for example, changes in postsynaptic
activity are able to alter the rates of receptor insertion,
recycling, and removal (25, 28, 31). At glutamatergic
synapses, activity similarly is able to alter the fate of
internalized AMPARs (121). The ways in which recep-
tor-associated proteins are regulated and how they, in
turn, modulate receptor density are only now begin-
ning to be understood. The work reviewed in this paper
represents the initial steps into understanding the
dynamics and behavior of receptor-associated proteins;
there remain a host of unanswered questions (Fig. 2).
For example, it has been shown that rapsyn appears to
accompany AChRs in the exocytic pathway (122, 123),
but it is not known whether rapsyn similarly traffics with
AChRs on internalization or during recycling. This
question is fundamental to understanding whether
receptor-associated proteins serve as anchors to recep-
tors once they are trapped at synaptic sites, or if the
receptor-associated proteins play a more active role,
chaperoning receptors during trafficking. Other ques-
tions about the cycling and trafficking of receptor-
associated proteins remain: are receptor-associated pro-
teins internalized individually or collectively with
receptors? Can all receptor-associated proteins inter-
nalize and then recycle back to the surface at the same
synapse or to neighboring synapses or folds? Do recep-
tor-associated proteins maintain their association with
receptors extrasynaptically? In fact, because they are
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already intracellularly localized, the definitions of such
terms as “internalization” and “recycling” are poten-
tially distinct from transmembrane receptors. As the
regulated trafficking of receptors has proven to be
essential for altering synaptic receptor number so, too,
may the regulation of receptor-associated protein traf-
ficking alter synaptic efficacy. A clearer understanding
of receptor-associated protein dynamics will be essen-
tial to further characterize these essential proteins.
Because of their intracellular localization, it seems
likely that genetic tagging and fluorescent microscopy
will continue to drive the research on the trafficking
and dynamics of receptor-associated proteins. In fact,
previous work has investigated some aspects of recep-
tor-associated protein trafficking using PSD-95-GFP fu-
sion proteins (91, 124). Although it is not known
whether it takes an intracellular path or moves exclu-
sively in the plane of the membrane, these studies
showed that PSD-95 is able to insert into synapses and
rapidly migrate between synaptic sites over time. This
indicates that PSD-95 enters and exits a synapse a
number of times before being degraded, which is
supported by the disparity between PSD-95 synaptic
dwell-time (1 h) and metabolic half-life (36 h) (91,
107). It will be interesting to see whether the recycling
of receptor-associated proteins is as prevalent as the
recycling of receptors and whether that aspect of
dynamics provides another major mechanism by which
protein dynamics can be rapidly modulated in order to
regulate synaptic strength.
CONCLUSIONS
The rapid turnover rate of postsynaptic density proteins
illustrated by rapsyn, gephyrin, and PSD-95 appears to
be the rule rather the exception. Along with PSD-95,
other PDZ proteins studied as GFP fusion proteins with
FRAP both at the drosophila NMJ and in hippocampal
neuronal cell cultures have proven to be very dynamic,
turning over even more rapidly than PSD-95 (100, 101,
125). Together, these emerging data challenge a view
of the postsynaptic scaffold as a static structure. Because
many of these scaffolding proteins play an important
role in the density, turnover, and localization of
postsynaptic receptors, this also indicates that changes
in scaffolding protein turnover may have dramatic
effects on synaptic structure, development, and plastic-
ity. Given the growing list of roles that postsynaptic
proteins play in establishing, maintaining, and modify-
ing the postsynaptic receptor density, it may be time to
imagine a different, more all-encompassing moniker
for these PSD regulators: the term “scaffolding pro-
teins” seems insufficient to describe the multifaceted
nature of these dynamic postsynaptic regulators.
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